enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Tiotropium bromide - Wikipedia

   en.wikipedia.org/wiki/Tiotropium_bromide

   Tiotropium is used as maintenance treatment of chronic obstructive pulmonary disease (COPD). [16] [17] It may also be used as an add-on therapy in people with moderate-to-severe asthma on medium to high dose inhaled corticosteroids (ICS). [18] [19] It is not however approved for acute exacerbations of COPD or acute worsening of asthma. [10]

3. Respimat - Wikipedia

   en.wikipedia.org/wiki/Respimat

   Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Its developer, Boehringer Ingelheim , is currently [ when? ] conducting approved in the U.S. with a variety of their products, such as tiotropium and ...

4. Bronchodilator - Wikipedia

   en.wikipedia.org/wiki/Bronchodilator

   Some examples of anticholinergics are tiotropium (Spiriva) and ipratropium bromide. [citation needed] Tiotropium is a long-acting, 24-hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Only available as an inhalant, ipratropium bromide is used in the treatment of asthma and COPD.

5. 3 Potential Game Changers for COPD - AOL

   www.aol.com/news/2013-07-16-3-potential-game...

   Over 13 million Americans have it. More than 120,000 of them die every year. Chronic obstructive pulmonary disease, or COPD, stands as the third leading cause of death in the U.S. The National ...

6. A Guide for Living With COPD - AOL

   www.aol.com/lifestyle/guide-living-copd...

   This chronic respiratory disease most commonly affects women aged 65 and older. But there are ways to manage the symptoms and slow down its progression. A Guide for Living With COPD

7. Boehringer to cut out-of-pocket costs for inhalers to $35 - AOL

   www.aol.com/news/boehringer-cut-pocket-costs...

   (Reuters) - Boehringer Ingelheim will reduce out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma to $35 per month starting June 1, the German drugmaker ...